Gout is a type of arthritis where swelling and
severe pain develops in joints, especially at the base of the big toe. Gout
occurs when uric acid builds up in blood and causes inflammation in the joints.
Symptoms include sudden onset of joint pain, joint swelling, heat in the
affected area and joint redness. Risk factors include obesity, high alcohol
intake, injury to a joint, long-standing kidney disease and high intake of
foods rich in purines.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide
Gouty Arthritis (Gout) - Pipeline Review, H1 2017, provides comprehensive
information on the therapeutics under development for Gouty Arthritis (Gout)
(Musculoskeletal Disorders), complete with analysis by stage of development,
drug target, mechanism of action (MoA), route of administration (RoA) and
molecule type. The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest news and
press releases.
Browse Detail Report With TOC @
The Gouty Arthritis (Gout) (Musculoskeletal
Disorders) pipeline guide also reviews of key players involved in therapeutic
development for Gouty Arthritis (Gout) and features dormant and discontinued
projects. The guide covers therapeutics under Development by Companies
/Universities /Institutes, the molecules developed by Companies in
Pre-Registration, Phase II, Phase I, Preclinical, Discovery and Unknown stages
are 1, 11, 2, 16, 2 and 3 respectively. Similarly, the Universities portfolio
in Preclinical stages comprises 1 molecules, respectively.
Gouty Arthritis (Gout) (Musculoskeletal
Disorders) pipeline guide helps in identifying and tracking emerging players in
the market and their portfolios, enhances decision making capabilities and
helps to create effective counter strategies to gain competitive advantage. The
guide is built using data and information sourced from proprietary databases,
company/university websites, clinical trial registries, conferences, SEC
filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources.
Additionally, various dynamic tracking processes ensure that the most recent
developments are captured on a real time basis.
Request A Sample copy of This
Report @
Note: Certain content / sections in the
pipeline guide may be removed or altered based on the availability and relevance
of data.
Scope
·
The pipeline
guide provides a snapshot of the global therapeutic landscape of Gouty
Arthritis (Gout) (Musculoskeletal Disorders).
·
The pipeline
guide reviews pipeline therapeutics for Gouty Arthritis (Gout) (Musculoskeletal
Disorders) by companies and universities/research institutes based on
information derived from company and industry-specific sources.
·
The pipeline
guide covers pipeline products based on several stages of development ranging
from pre-registration till discovery and undisclosed stages.
·
The pipeline
guide features descriptive drug profiles for the pipeline products which
comprise, product description, descriptive licensing and collaboration details,
R&D brief, MoA & other developmental activities.
·
The pipeline
guide reviews key companies involved in Gouty Arthritis (Gout) (Musculoskeletal
Disorders) therapeutics and enlists all their major and minor projects.
·
The pipeline
guide evaluates Gouty Arthritis (Gout) (Musculoskeletal Disorders) therapeutics
based on mechanism of action (MoA), drug target, route of administration (RoA)
and molecule type.
·
The pipeline
guide encapsulates all the dormant and discontinued pipeline projects.
Reasons to
buy
1. Procure strategically important competitor
information, analysis, and insights to formulate effective R&D strategies.
2. Recognize emerging players with potentially
strong product portfolio and create effective counter-strategies to gain
competitive advantage.
3. Find and recognize significant and varied
types of therapeutics under development for Gouty Arthritis (Gout)
(Musculoskeletal Disorders).
4. Classify potential new clients or partners in
the target demographic.
5. Develop tactical initiatives by understanding
the focus areas of leading companies.
6. Plan mergers and acquisitions meritoriously by
identifying key players and it's most promising pipeline therapeutics.
7. Formulate corrective measures for pipeline
projects by understanding Gouty Arthritis (Gout) (Musculoskeletal Disorders)
pipeline depth and focus of Indication therapeutics.
8. Develop and design in-licensing and
out-licensing strategies by identifying prospective partners with the most
attractive projects to enhance and expand business potential and scope.
9. Adjust the therapeutic portfolio by
recognizing discontinued projects and understand from the know-how what drove
them from pipeline.
Browse More Pharmaceuticals
& Healthcare Related Market Research Reports:
• Ewing
Sarcoma - Pipeline Review, H1 2017 -
• Anaplastic Astrocytoma - Pipeline Review, H2
2017 -
• Type 2
Diabetes - Pipeline Review, H1 2017 -
http://www.hexareports.com/report/type-2-diabetes-pipeline-review-h1-2017
No comments:
Post a Comment